Unexpected anaphylaxis after completing a desensitization protocol to Oxaliplatin: successful adjuvant use of Omalizumab
J. investig. allergol. clin. immunol
; 29(1): 53-55, 2019. tab
Article
in English
| IBECS
| ID: ibc-183966
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
No disponible
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Desensitization, Immunologic
/
Omalizumab
/
Hypersensitivity, Immediate
/
Anaphylaxis
Limits:
Female
/
Humans
Language:
English
Journal:
J. investig. allergol. clin. immunol
Year:
2019
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario Gregorio Marañón/Spain